LIFE-BTK Randomized Controlled Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 261 participants.

Also called NCT04227899

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 261 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT04227899
Other papers using this trial's data
  • Drug-Eluting Resorbable Scaffold Versus Balloon Angioplasty for Below-the-Knee Peripheral Artery Disease: 2-Year Results From the LIFE-BTK Trial Circulation, 2025-10-14 DOI, PubMed 40927852, PMC12513053 In the PMC Open Access subset under CC BY-NC-ND.
  • Drug-Eluting Resorbable Scaffold versus Angioplasty for Infrapopliteal Artery Disease The New England journal of medicine, 2024-01-04 DOI, PubMed 37888915
  • Long-Term Outcomes of a Drug-Eluting Resorbable Scaffold vs Angioplasty in Infrapopliteal Chronic Limb-Threatening Ischemia: 3-Year Results From the LIFE-BTK Trial Journal of the American College of Cardiology, 2026-07-07 DOI, PubMed 42126372

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, Hong Kong SAR China, New Zealand, Singapore, Taiwan (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04227899. Randomized; single masking; primary purpose treatment. Start 2020-08-18 (actual); primary completion 2023-08-17 (actual). Results posted on 2024-09-19.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
LIFE-BTK Randomized Controlled Trial
Acronym
LIFE-BTK
Condition
Critical Limb Ischemia (CLI)
Intervention (Device)
Esprit BTK Device
Intervention (Device)
Percutaneous Transluminal Angioplasty (PTA) Device
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct04227899
Content hash
26a9080806e46bd91c8f9f9991421aa82c27e22257220a3f0d1c6b9cbbeebe30